National Health Investors, Inc. (NHI) Downgraded by Zacks Investment Research

Zacks Investment Research lowered shares of National Health Investors, Inc. (NYSE:NHI) from a buy rating to a hold rating in a research note published on Thursday morning.

According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “

A number of other brokerages have also issued reports on NHI. BidaskClub upgraded shares of National Health Investors from a hold rating to a buy rating in a research report on Thursday, June 29th. Mizuho restated a neutral rating on shares of National Health Investors in a research report on Wednesday, June 28th. Stifel Nicolaus raised their target price on shares of National Health Investors from $80.00 to $82.00 and gave the stock a buy rating in a research report on Wednesday, June 21st. ValuEngine lowered shares of National Health Investors from a buy rating to a hold rating in a research report on Tuesday, June 13th. Finally, Bank of America Corporation lowered shares of National Health Investors from a neutral rating to an underperform rating and set a $76.00 target price on the stock. in a research report on Monday, May 22nd. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the stock. National Health Investors has a consensus rating of Hold and an average price target of $80.50.

Shares of National Health Investors (NYSE NHI) opened at 79.99 on Thursday. The stock has a market capitalization of $3.28 billion, a P/E ratio of 20.54 and a beta of 0.56. National Health Investors has a 12-month low of $66.31 and a 12-month high of $81.29. The stock has a 50 day moving average of $78.56 and a 200 day moving average of $75.95.

National Health Investors (NYSE:NHI) last announced its earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.29 by ($0.36). The business had revenue of $69.84 million for the quarter, compared to analysts’ expectations of $67.68 million. National Health Investors had a return on equity of 12.56% and a net margin of 59.24%. The business’s revenue was up 14.1% on a year-over-year basis. During the same quarter last year, the business posted $1.22 earnings per share. Equities research analysts anticipate that National Health Investors will post $3.85 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “National Health Investors, Inc. (NHI) Downgraded by Zacks Investment Research” was published by Equities Focus and is the sole property of of Equities Focus. If you are viewing this story on another domain, it was copied illegally and republished in violation of United States and international copyright laws. The legal version of this story can be viewed at https://www.equitiesfocus.com/2017/09/17/national-health-investors-inc-nhi-downgraded-by-zacks-investment-research.html.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 10th. Investors of record on Friday, September 29th will be given a $0.95 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $3.80 dividend on an annualized basis and a yield of 4.75%. National Health Investors’s dividend payout ratio (DPR) is 97.69%.

In related news, insider Kevin Carlton Pascoe sold 2,000 shares of National Health Investors stock in a transaction on Thursday, August 24th. The shares were sold at an average price of $79.80, for a total value of $159,600.00. Following the transaction, the insider now directly owns 21,228 shares in the company, valued at approximately $1,693,994.40. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 5.19% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the business. Carroll Financial Associates Inc. purchased a new stake in shares of National Health Investors during the 2nd quarter worth $158,000. Yorktown Management & Research Co Inc purchased a new stake in shares of National Health Investors during the 2nd quarter worth $214,000. Allegis Investment Advisors LLC purchased a new stake in shares of National Health Investors during the 2nd quarter worth $216,000. Quantbot Technologies LP purchased a new stake in shares of National Health Investors during the 1st quarter worth $201,000. Finally, Profund Advisors LLC boosted its position in shares of National Health Investors by 4.3% during the 2nd quarter. Profund Advisors LLC now owns 3,126 shares of the real estate investment trust’s stock worth $248,000 after purchasing an additional 130 shares in the last quarter. Institutional investors own 70.58% of the company’s stock.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply